Diabete vital signs monitor MDE SensoriScan

compactsensory nerve conduction thresholdfor chronic care

The MDE SensoriScan (formerly Neurometer) is an electrodiagnostic device designed for automated neuroselective sensory nerve conduction threshold assessment, specifically targeting the painless current perception threshold (CPT). Through microprocessor-controlled, neuro-selective electrical stimuli, the system swiftly and painlessly quantifies the conduction threshold and functional integrity of large and small myelinated, as well as small unmyelinated sensory nerve fibers individually, on any skin surface of the body. The MDE SensoriScan has been proven useful for clinicians in selecting the most appropriate therapy, as well as in monitoring and evaluating interventions in the following 
key application areas. MDE SensoriScan tests detects prediabetic and diabetic nerve damage. Testing the longest nerve fibres in the body, located at the tip of the toe, allows the earliest detection. This allows early therapeutic intervention before the damage is irreversible. Examination of the higher parts of the foot allows the earliest stages of healing to be monitored. 02 Disc problems, whiplash / low back pain The MDE SensoriScan immediately detects and assesses the difference between a neurological problem and a spinal muscle injury. 03 Early Carpal Tunnel Syndrome MDE SensoriScan detects the presence of CTS earlier than any other test and then provides electrophysiological confirmation of treatment efficacy and progress monitoring.